Angelin, Alessia https://orcid.org/0000-0002-7115-5451
Keller, Kierstin
Lu, Peiran https://orcid.org/0009-0001-5096-3046
Guarnieri, Joseph W.
Widjaja, Gabrielle A.
Sule, Rasheed
Janssen, Kevin https://orcid.org/0000-0002-6980-9575
Olali, Arnold
Cen, Zimu https://orcid.org/0009-0003-4732-6366
Carosi, Valeria
Beauplan, Maina
Murdock, Deborah G.
Potluri, Prasanth
Pei, Liming https://orcid.org/0000-0002-1924-0333
Wallace, Douglas C. https://orcid.org/0000-0002-7480-8278
Funding for this research was provided by:
U.S. Department of Defense (W81XWH22-1-0560)
U.S. Department of Defense (W81XWH22-1-0561)
U.S. Department of Defense (W81XWH22-1-0058)
U.S. Department of Health & Human Services | National Institutes of Health (R01CA259635)
U.S. Department of Health & Human Services | National Institutes of Health (R01AG078814)
U.S. Department of Health & Human Services | National Institutes of Health (R01DK111495)
U.S. Department of Health & Human Services | National Institutes of Health (U54HL165442)
U.S. Department of Health & Human Services | National Institutes of Health (U01HL166058)
American Heart Association (23DIVSUP1069865)
American Heart Association (227477)
Article History
Received: 7 February 2025
Accepted: 21 November 2025
First Online: 15 December 2025
Competing interests
: D.C.W. is a consultant for Pano Pharmaceuticals and Medical Excellence Capital. The remaining authors declare no competing interests.